Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Medulloblastomas are among the most common malignancies in childhood, and they are associated with substantial mortality and morbidity. The molecular pathogenesis as well as the ontogeny of these neoplasms is still poorly understood. We have generated a mouse model for medulloblastoma by Cre-LoxP-mediated inactivation of Rb and p53 tumor suppressor genes in the cerebellar external granular layer (EGL) cells. GFAP-Cre-mediated recombination was found both in astrocytes and in immature precursor cells of the EGL in the developing cerebellum. GFAP-Cre;Rb(LoxP/LoxP);p53(-/- or LoxP/LoxP) mice developed highly aggressive embryonal tumors of the cerebellum with typical features of medulloblastoma. These tumors were identified as early as 7 weeks of age on the outer surface of the molecular layer, corresponding to the location of the EGL cells during development. Our results demonstrate that loss of function of RB is essential for medulloblastoma development in the mouse and strongly support the hypothesis that medulloblastomas arise from multipotent precursor cells located in the EGL.

[1]  H. Zhen,et al.  Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag‐p53 and Tag‐pRb complexes in human brain tumors , 1999, Cancer.

[2]  M. Vooijs,et al.  Developmental defects and tumor predisposition in Rb mutant mice , 1999, Oncogene.

[3]  D. H. Randle,et al.  Tumor spectrum in ARF-deficient mice. , 1999, Cancer research.

[4]  Jonas Frisén,et al.  Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System , 1999, Cell.

[5]  Y. Yonekawa,et al.  Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen , 1999, Brain pathology.

[6]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[7]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[8]  G. Fulci,et al.  p53 and Brain Tumors: From Gene Mutations to Gene Therapy , 1998, Brain pathology.

[9]  M. Vooijs,et al.  Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse , 1998, Oncogene.

[10]  Fred H. Gage,et al.  The Adult Rat Hippocampus Contains Primordial Neural Stem Cells , 1997, Molecular and Cellular Neuroscience.

[11]  H. Zoghbi,et al.  Math1 is essential for genesis of cerebellar granule neurons , 1997, Nature.

[12]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[13]  A. Aguzzi,et al.  Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice , 1997, Oncogene.

[14]  A. Berns,et al.  Cre-mediated somatic site-specific recombination in mice. , 1997, Nucleic acids research.

[15]  P. Kleihues,et al.  Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.

[16]  A. Messing,et al.  Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice , 1996, The Journal of Neuroscience.

[17]  H. Zoghbi,et al.  Evolutionary conservation of sequence and expression of the bHLH protein Atonal suggests a conserved role in neurogenesis. , 1996, Human molecular genetics.

[18]  K. Rajewsky,et al.  Conditional gene targeting. , 1996, The Journal of clinical investigation.

[19]  P. Kleihues,et al.  Infrequent alterations of the p15, p16, CDK4 and CYCLIN D1 genes in non‐astrocytic human brain tumors , 1996, International journal of cancer.

[20]  L. Donehower,et al.  Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas , 1995, Molecular and cellular biology.

[21]  E. Wagner,et al.  Activation of HIV transcription by human foamy virus in transgenic mice. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[22]  W. Cavenee,et al.  Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. , 1995, Cancer research.

[23]  A. Aguzzi,et al.  Deregulated expression of PAX5 in medulloblastoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Weller,et al.  Focal brain damage enhances experimental allergic encephalomyelitis in brain and spinal cord , 1995, Neuropathology and applied neurobiology.

[25]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[26]  J. Craig,et al.  Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins , 1995, The Journal of cell biology.

[27]  R. Kageyama,et al.  A Mammalian Helix-Loop-Helix Factor Structurally Related to the Product of Drosophila Proneural Gene atonal Is a Positive Transcriptional Regulator Expressed in the Developing Nervous System(*) , 1995, The Journal of Biological Chemistry.

[28]  L. Donehower,et al.  Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. , 1995, Cancer research.

[29]  L. Mucke,et al.  Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo comparison of distinct GFAP‐lacZ transgenes , 1995, Glia.

[30]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.

[31]  R. Weinberg,et al.  Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. , 1994, The EMBO journal.

[32]  A. Berns,et al.  Developmental rescue of an embryonic‐lethal mutation in the retinoblastoma gene in chimeric mice. , 1994, The EMBO journal.

[33]  A. Bradley,et al.  Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. , 1994, Genes & development.

[34]  R. McLendon,et al.  Immunohistochemistry of the Glial Fibrillary Acidic Protein: Basic and Applied Considerations , 1994, Brain pathology.

[35]  B. Scheithauer,et al.  Aggressive medulloblastoma with high-level N-myc amplification. , 1994, Mayo Clinic proceedings.

[36]  L. Mucke,et al.  Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice , 1994, Nature.

[37]  J. Trojanowski,et al.  Cerebellar Dysplasias in Humans: Development and Possible Relationship to Glial and Primitive Neuroectodermal Tumors of the Cerebellar Vermis , 1994, Journal of neuropathology and experimental neurology.

[38]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[39]  J. Trojanowski,et al.  Expression of neuronal and glial polypeptides during histogenesis of the human cerebellar cortex including observations on the dentate nucleus , 1993, The Journal of comparative neurology.

[40]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[41]  K. Rajewsky,et al.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.

[42]  Iver Petersen,et al.  Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system , 1993, Molecular carcinogenesis.

[43]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[44]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[45]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[46]  A. Bignami,et al.  The astrocyte-extracellular matrix complex in CNS myelinated tracts: a comparative study on the distribution of hyaluronate in rat, goldfish and lamprey , 1992, Journal of neurocytology.

[47]  I. Petersen,et al.  p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. , 1992, Cancer research.

[48]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[49]  A. Aguzzi,et al.  Retrovirus‐Mediated Oncogene Transfer into Neural Transplants , 1991, Brain pathology.

[50]  L. Mucke,et al.  Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. , 1991, The New biologist.

[51]  G. Basso,et al.  N-MYC and C-MYC Oncogenes Amplification in Medulloblastomas. Evidence of Particularly Aggressive Behavior of a Tumor with C-MYC Amplification , 1991, Tumori.

[52]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[53]  K. Mikoshiba,et al.  Cell‐Specific Expression of the Mouse Glial Fibrillary Acidic Protein Gene: Identification of the Cis‐ and Trans‐Acting Promoter Elements for Astrocyte‐Specific Expression , 1990, Journal of neurochemistry.

[54]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[55]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[56]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[57]  T. Dryja,et al.  Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. Eng.  Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes , 1985, Journal of Neuroimmunology.

[59]  L. Eng,et al.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. , 1972, Brain research.

[60]  P. Bailey,et al.  MEDULLOBLASTOMA CEREBELLI: A COMMON TYPE OF MIDCEREBELLAR GLIOMA OF CHILDHOOD , 1925 .